Fanapt Approval Expanded to Include Treatment of Bipolar I Disorder

The FDA has expanded the approval of Fanapt® (iloperidone) to include the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.

Related Keywords

Mihaelh Polymeropoulos , ,Drug Administration ,Young Mania Rating Scale ,Clinician Global Impression ,